AlphaMark Advisors’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$231K Sell
4,055
-1,913
-32% -$113K 0.1% 121
2024
Q3
$351K Sell
5,968
-270
-4% -$14.7K 0.12% 130
2024
Q2
$336K Buy
6,238
+393
+7% +$21.6K 0.12% 122
2024
Q1
$337K Buy
5,845
+3,245
+125% +$168K 0.12% 131
2023
Q4
$125K Buy
2,600
+1,000
+63% +$47.7K 0.05% 250
2023
Q3
$82K Buy
+1,600
New +$84.7K 0.04% 272
2020
Q1
Sell
-213
Closed -$6K 589
2019
Q4
$6K Hold
213
﹤0.01% 384
2019
Q3
$6K Buy
+213
New +$6.16K ﹤0.01% 378

Other funds holding CTVA

AlphaMark Advisors's CTVA Position: Q4 2024 in Review

AlphaMark Advisors reduced its Corteva (CTVA) stake by 32% in Q4 2024, selling an estimated $113K and leaving 4,055 shares worth $231K. The position accounts for 0.1% of the portfolio, ranked #121.

AlphaMark Advisors first reported a position in CTVA in Q3 2019 and has held it in 8 quarters since. The position peaked at $351K in Q3 2024. 1,300 funds tracked by Wall St. Rank hold CTVA as of Q4 2024.

  • AlphaMark Advisors held 4,055 shares of Corteva worth $231K as of Q4 2024.
  • AlphaMark Advisors sold 1,913 Corteva shares in Q4 2024, an estimated $113K.
  • Corteva made up 0.1% of AlphaMark Advisors's portfolio in Q4 2024, its #121 holding.
  • AlphaMark Advisors first reported a position in Corteva in Q3 2019 and has held it in 8 quarters since.
  • AlphaMark Advisors's Corteva position peaked at $351K in Q3 2024.
  • 1,300 funds tracked by Wall St. Rank held Corteva as of Q4 2024.

Based on AlphaMark Advisors's 13F filing for Q4 2024, filed 21 Jan 2025.